|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Fiterman Pharma
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Fiterman Pharma SRL Previous name(s) MARK PHARMACEUTICS SRL (2008) Headquarters 127, acurari St.; IASI; Iasi |
Status: Non-Listed Legal Form: Limited Liability Company Operational Status: Operational CUI: 06787981 Incorporation Date: January 1, 1994 Total Employees: 120 Tel: 00 40-332-401.983 |
|
Company Description |
|
The company was established in Iasi, in 1995, as the first drug producer under full Romanian ownership from Moldavia, under the name of MARK PHARMACEUTICS SRL. In 2008 the company's name changed to Fiterman Pharma SRL. From the modest beginning of a small production laboratory of drugs, with only four employees, in 14 years the company includes over 100 employees and about 50 products in portfolio. |
Company Analysis |
| According to the Individual - Non-Audited financial statement for the Year of 2011, total net operating revenues increased with 38.98%, from RON 30,579,316 to RON 42,497,841 . Operating result increased from RON 12,743,085 to RON 18,276,963 which means 43.43% change. The results of the period increased 32.60% reaching RON 8,010,168 at the end of the period against RON 6,040,852 last year. Return on equity (Net income/Total equity) went from 28.62% to 27.94%, the Return On Asset (Net income / Total Asset) went from 18.71% to 17.87% and the Net Profit Margin (Net Income/Net Sales) went from 19.75% to 18.85% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 56.37% compared to 53.02% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 2.07 to 2.61 when compared to the previous year. |
Key Executives |
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2011 Y (non-cons) |
2011 H1 (non-cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| Creditinfo - Financial Standard 1026 | ||
| ||
| Unit | 1 | 1 |
| ||
Balance Sheet
| ||
Total Assets |
44,824,916 |
32,894,184 |
| ||
Current Assets |
XX,XXX,XXX |
XX,XXX,XXX |
| ||
Total Liabilities |
XX,XXX,XXX |
X,XXX,XXX |
| ||
Shareholders Equity |
XX,XXX,XXX |
XX,XXX,XXX |
| ||
Current Liabilities |
XX,XXX,XXX |
X,XXX,XXX |
| ||
| * All the accounts are in RON. | ||
Income Statement
| ||
Total Operating Revenue |
XX,XXX,XXX |
XX,XXX,XXX |
| ||
Operational Profit (Loss) |
XX,XXX,XXX |
X,XXX,XXX |
| ||
Net Profit (Loss) |
X,XXX,XXX |
X,XXX,XXX |
| ||
| * All the accounts are in RON. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
XX.XX% |
XX.XX% |
| ||
Annualised Return on Assets (ROA) |
XX.XX% |
XX.XX% |
| ||
Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Annualised Return on Equity (ROE) |
XX.XX% |
XX.XX% |
| ||
Return on Sales (ROS) |
XX.XX% |
XX.XX% |
| ||
Return on Capital |
XX.XX% |
XX.XX% |
| ||
Gross Profit Margin |
XX.XX% |
XX.XX% |
| ||
Operating Profit Margin |
XX.XX% |
XX.XX% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
X.XXx |
X.XXx |
| ||
Inventory Turnover |
X.XXx |
X.XXx |
| ||
Current asset turnover |
X.XXx |
X.XXx |
| ||
Fixed-asset turnover |
X.XXx |
X.XXx |
| ||
Asset Turnover |
X.XXx |
X.XXx |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XX,XXX,XXX |
X,XXX,XXX |
| ||
EBITDA |
XX,XXX,XXX |
X,XXX,XXX |
| ||
Bookvalue (BV) |
XX,XXX,XXX |
XX,XXX,XXX |
| ||
Net Cash |
-XX,XXX,XXX |
-X,XXX,XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX.XX% |
XXX.XX% |
| ||
Quick ratio |
XXX.XX% |
XXX.XX% |
| ||
Doom's day ratio |
X.XX% |
X.XX% |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX.XX% |
XXX.XX% |
| ||
Interest Coverage Ratio |
X.XX% |
X.XX% |
| ||
Debt to equity |
XX.XX% |
XX.XX% |
| ||
Debt to total assets |
XX.XX% |
XX.XX% |
| ||
Long Term Debt to Capital |
XX.XX% |
XX.XX% |
| ||
 |